Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Doreen Kamori

AfOx Fellow 2024

Dr Doreen Kamori is a Senior Lecturer and Researcher in the Department of Microbiology and Immunology at Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. Currently, she is a visiting fellow at the Nuffield Department of Medicine at the University of Oxford, joining the Africa Oxford Initiative (AfOx) Visiting Fellowship programme. She will be working with Professor Sarah Rowland-Jones.

Dr Kamori’s research specializes in HIV, specifically focusing on HIV drug resistance, viral evolution, immunology and co-infections in high-risk populations. Her work includes contributions to a national survey on HIV drug resistance in Tanzania, supported by the National AIDS Control Programme. She has authored multiple studies on HIV viral polymorphisms and has led projects assessing co-infections such as hepatitis B in HIV-positive individuals. Dr Kamori completed her PhD in Viral Immunology at Kumamoto University, Japan, and has been instrumental in advancing HIV research initiatives within Tanzania.

During her fellowship at Oxford, Dr Kamori will work on her project, "Laboratory-Based HIV Drug Resistance Surveillance Using Blood Sample Remnants." This research aims to use existing HIV viral load data to conduct a cost-effective, representative analysis of HIV drug resistance in Tanzania using next-generation sequencing techniques. Dr Kamori’s project seeks to improve HIV drug resistance monitoring nationwide, thereby informing policy and enhancing treatment outcomes for people living with HIV.